CRANIAL ACTINOMYCOSIS AND SEPTIC CEREBRAL VENOUS THROMBOSIS

2021 ◽  
pp. 8-8
Author(s):  
Moses P Moorthy ◽  
Shraddha Laxmidhar Mohanty ◽  
Shifa Beegum

60 years old female diagnosed to be having CNS actinomycosis 3 years back presented with neurovisual loss for which she was treated with penicillin. Her vision improved and she was discharged. Now she presented with severe headache in the occipital region of 3 months duration. On general examination she was conscious and alert. On CNS examination she had bilateral papilloedema with secondary optic atrophy. Her motor, sensory and cerebellar functions were normal.

2018 ◽  
Vol 15 (1) ◽  
pp. 29-31
Author(s):  
Basant Pant ◽  
Malika Bajracharya ◽  
Avinash Chandra ◽  
Ramita Bati ◽  
Reema Rajbhadari ◽  
...  

Cerebral Venous Thrombosis (CVT) is a rare form of Stroke characterized by thrombus formation in the cerebral veins. CVT is a result of various reasons among which the hyperthyroidism is not so frequently encountered. This is probably the first case report published from Nepal. The aim of this case report is to give the message that persistent severe headache in patient with hyperthyroidism can be the red flag and needs to be investigated further. We present a case of a 35 years old female who presented with complaints of severe headache and persistent in nature associated with vomiting since 5 days. She was a diagnosed subacute thryroiditis and under medicine from 1 month before presenting to us. Her Magnetic Resonance Venography (MRV) brain showed venous thrombosis within superior saggital sinus, left transverse sinus and sigmoid sinus. Her thyroid function test showed pretreatment T3 of 2.98 ng/ml T4 of 1.02 mg/ ml and TSH of 0.12 μIU/L. She was kept on anticoagulants and other supportive measures. The patient showed improving status with the conservative management.Nepal Journal of Neuroscience 15:29-31, 2018


Stroke ◽  
2021 ◽  
Author(s):  
Kangxiang Ji ◽  
Chen Zhou ◽  
Longfei Wu ◽  
Weili Li ◽  
Milan Jia ◽  
...  

Background and purpose: Which factors will influence the presence of severe residual headache after cerebral venous thrombosis (CVT) is unclear. The purpose of this study was to identify risk factors for severe residual headache in a large single-center cohort of patients with CVT. Methods: We consecutively included eligible patients with CVT from a prospective stroke registry. Severe residual headache was defined as a residual headache attack requiring bed rest or hospital admission within 1 month before the last follow-up visit. We identified the risk factors of severe residual headache in all survivors and in those with favorable functional outcome (a modified Rankin Scale score, 0–2). Results: A total of 325 patients’ data were analyzed. At the last follow-up (median 13 months), 43 patients (13.2%) reported severe headache. In the multivariable analysis, isolated intracranial hypertension (odds ratio [OR], 3.309 [95% CI, 1.434–7.634]; P =0.005), CVT recurrence (OR, 4.722 [95% CI, 1.639–13.602]; P =0.004), and no recanalization (OR, 10.158 [95% CI, 4.194–24.600]; P <0.001) were independently associated with severe headache. Severe headache was more frequent in patients with unfavorable outcome (11/25 [44.0%] versus 32/300 [10.7%]; P <0.001). In patients with favorable outcome, the risk factors for severe headache were isolated intracranial hypertension (OR, 3.236 [95% CI, 1.268–8.256]; P =0.014) and no recanalization (OR, 7.863 [95% CI, 3.120–19.812]; P <0.001). Conclusions: Isolated intracranial hypertension, CVT recurrence, and no recanalization increased the risk for severe residual headache after CVT.


Sign in / Sign up

Export Citation Format

Share Document